RESEARCH
Organic certicates
Kosher certicate
FDA certicate
Halal Certificate
Team
Gallery
Published Journal Articles
Lansky EP.
Beware of pomegranates bearing 40% ellagic Acid. J Med Food. 2006 Spring;9(1):119-22.
Aslam MN, Lansky EP, Varani J.
Pomegranate as a cosmeceutical source: Pomegranate fractions promote proliferation and procollagen synthesis and inhibit matrix metalloproteinase-1 production in human skin cells. J Ethnopharmacol. 2006 Feb 20;103(3):311-8. Epub 2005 Oct 10.
Lansky EP, Harrison G, Froom P, Jiang WG.
Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel. Invest New Drugs. 2005 Mar;23(2):121-2. Erratum in: Invest New Drugs. 2005 Aug;23(4):379.
Mehta R, Lansky EP.
Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture. Eur J Cancer Prev. 2004 Aug;13(4):345-8.
Lansky EP, Jiang W, Mo H, Bravo L, Froom P, Yu W, Harris NM, Neeman I, Campbell MJ.
Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Invest New Drugs. 2005 Jan;23(1):11-20.
Albrecht M, Jiang W, Kumi-Diaka J, Lansky EP, Gommersall LM, Patel A, Mansel RE, Neeman I, Geldof AA, Campbell MJ.
Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. J Med Food. 2004 Fall;7(3):274-83.
Kawaii S, Lansky EP.
Differentiation-promoting activity of pomegranate (Punica granatum) fruit extracts in HL-60 human promyelocytic leukemia cells. J Med Food. 2004 Spring;7(1):13-8.
Toi M, Bando H, Ramachandran C, Melnick SJ, Imai A, Fife RS, Carr RE, Oikawa T, Lansky EP.
Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo. Angiogenesis. 2003;6(2):121-8.
van Elswijk DA, Schobel UP, Lansky EP, Irth H, van der Greef J.
Rapid dereplication of estrogenic compounds in pomegranate (Punica granatum) using on-line biochemical detection coupled to mass spectrometry. Phytochemistry. 2004 Jan;65(2):233-41.
Hora JJ, Maydew ER, Lansky EP, Dwivedi C.
Chemopreventive effects of pomegranate seed oil on skin tumor development in CD1 mice. J Med Food. 2003 Fall;6(3):157-61.
Kim ND, Mehta R, Yu W, Neeman I, Livney T, Amichay A, Poirier D, Nicholls P, Kirby A, Jiang W, Mansel R, Ramachandran C, Rabi T, Kaplan B, Lansky E.
Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res Treat. 2002 Feb;71(3):203-17
Schubert SY, Lansky EP, Neeman I.
Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids. J Ethnopharmacol. 1999 Jul;66(1):11-7
To request full articles,
click here
NEWS
HOME PAGE
POMEGRANATE
INTELLECTUAL PROPERTY
FUNCTIONAL INGREDIENTS
DRUG DEVELOPMENT
SPAGYRIC SPIRITS
CONSULTING
RESEARCH
INVESTMENTS
LINKS
Request
Information
Created by
GraphoNET Ltd.
Rimonest Ltd.
1 Hadekalim Street
POB 9945
Haifa 34341 ISRAEL
Israel Cell +972 545 273 156
Tel +972 4 864 5011
Fax +972 3 521 4728
info@rimonest.com
© 2001-2006
Rimonest Ltd.
All rights reserved.